![The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma](https://ars.els-cdn.com/content/image/1-s2.0-S0169500218303040-gr1.jpg)
The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma
![Distribution of carcinoembryonic antigen (CEA) according to TNM stage... | Download Scientific Diagram Distribution of carcinoembryonic antigen (CEA) according to TNM stage... | Download Scientific Diagram](https://www.researchgate.net/publication/249967493/figure/fig2/AS:202980243578886@1425405669464/Distribution-of-carcinoembryonic-antigen-CEA-according-to-TNM-stage-and-N-stage-A.png)
Distribution of carcinoembryonic antigen (CEA) according to TNM stage... | Download Scientific Diagram
![Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples | British Journal of Cancer Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2015.202/MediaObjects/41416_2015_Article_BFbjc2015202_Fig1_HTML.jpg)